Epigral Ltd vs Grauer Weil India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 18, 2026

Key Highlights

The Latest Trading Price of Epigral Ltd is ₹ 856.45 as of 18 Mar 15:30 . The P/E Ratio of Epigral Ltd changed from 16 on March 2022 to 22.9 on March 2025 . This represents a CAGR of 9.38% over 4 yearsThe P/E Ratio of Grauer & Weil (India) Ltd changed from 12.9 on March 2021 to 23.6 on March 2025 . This represents a CAGR of 12.84% over 5 years The Market Cap of Epigral Ltd changed from ₹ 4045 crore on March 2022 to ₹ 8191 crore on March 2025 . This represents a CAGR of 19.29% over 4 yearsThe Market Cap of Grauer & Weil (India) Ltd changed from ₹ 888.69 crore on March 2021 to ₹ 3719 crore on March 2025 . This represents a CAGR of 33.15% over 5 years The revenue of Epigral Ltd for the Dec '25 is ₹ 602.68 crore as compare to the Sep '25 revenue of ₹ 589.1 crore. This represent the growth of 2.31% The revenue of Grauer & Weil (India) Ltd for the Dec '25 is ₹ 302.54 crore as compare to the Sep '25 revenue of ₹ 302.51 crore. This represent the growth of 0.01% The ebitda of Epigral Ltd for the Dec '25 is ₹ 108.26 crore as compare to the Sep '25 ebitda of ₹ 133.8 crore. This represent the decline of -19.09% The ebitda of Grauer & Weil (India) Ltd for the Dec '25 is ₹ 50.59 crore as compare to the Sep '25 ebitda of ₹ 54.66 crore. This represent the decline of -7.45% The net profit of Epigral Ltd changed from ₹ 85.87 crore to ₹ 39.11 crore over 7 quarters. This represents a CAGR of -36.20% The net profit of Grauer & Weil (India) Ltd changed from ₹ 50.71 crore to ₹ 32.33 crore over 7 quarters. This represents a CAGR of -22.68% The Dividend Payout of Epigral Ltd changed from 5.88 % on March 2023 to 7.26 % on March 2025 . This represents a CAGR of 7.28% over 3 yearsThe Dividend Payout of Grauer & Weil (India) Ltd changed from 16.28 % on March 2021 to 14.44 % on March 2025 . This represents a CAGR of -2.37% over 5 years .

About Epigral Ltd

Epigral Limited was erstwhile incorporated as 'Meghmani Finechem Limited' in 2007, which is engaged in manufacturing and selling of Chlor Alkali & its Derivatives and also in Trading of Agrochemical products.
The Company was incorporated as a subsidiary of Meghmani Organics Limited. Meghmani Finechem Limited (MFL) was demerged from Meghmani Organics Limited (MOL) as a going concern, through the Scheme of Arrangement for Demerger and the said Scheme became effective from May 10, 2021.
The Chlor-Alkali business commissioned in 2009, growing from an installed capacity of 1,88,000 TPA in 2015 to 3,15,000 TPA at the close of FY 2020-21.
The Company is now among the leading players in India's chlor alkali industry.
In terms of the said Scheme, the Company allotted 2,39,03,029 Equity Shares of Rs 10/- each on 20th May, 2021 to the shareholders of Meghmani Organics Limited.

About Grauer & Weil (India) Ltd

Incorporated in 1957 as a private limited company, Grauer & Weil (India) Private Limited (GWL) was converted into a public limited company in February, 1961.
The Company is a pioneer in the world to offer complete corrosion protection solutions for all types of substrates across various industry segments.
It is presently engaged in the business of manufacturing and selling of Surface Finishings besides Engineering and Mall business.
The Company presently has its manufacturing facilities in Dadra, Vapi (Gujarat), Barotiwala (Himachal Pradesh), Samba (Jammu & Kashmir) besides Engineering division at Khed (Pune District) and Mall at Kandivli (Mumbai). After the start up of Chemical production in 1957, the Company ventured into manufacturing of engineering equipment in 1964 to provide complete electroplating solutions to its customers.

FAQs for the comparison of Epigral Ltd and Grauer & Weil (India) Ltd

Which company has a larger market capitalization, Epigral Ltd or Grauer & Weil (India) Ltd?

Market cap of Epigral Ltd is 3,694 Cr while Market cap of Grauer & Weil (India) Ltd is 2,677 Cr

What are the key factors driving the stock performance of Epigral Ltd and Grauer & Weil (India) Ltd?

The stock performance of Epigral Ltd and Grauer & Weil (India) Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Epigral Ltd and Grauer & Weil (India) Ltd?

As of March 18, 2026, the Epigral Ltd stock price is INR ₹856.45. On the other hand, Grauer & Weil (India) Ltd stock price is INR ₹59.05.

How do dividend payouts of Epigral Ltd and Grauer & Weil (India) Ltd compare?

To compare the dividend payouts of Epigral Ltd and Grauer & Weil (India) Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.